Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-Centre, Prospective, Open Label, Randomized Trial to Assess the Efficacy and Safety of Moxifloxacin Versus Levofloxacin Plus Metronidazole in the Treatment of Community-Acquired Pneumonia With Aspiration Factors

NCT00752947 is registered in ClinicalTrials.gov with Beijing Hospital as lead sponsor.

NCT NCT00752947
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00752947 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-Centre, Prospective, Open Label, Randomized Trial to Assess the Efficacy and Safety of Moxifloxacin Versus Levofloxacin Plus Metronidazole in the Treatment of Community-Acquired Pneumonia With Aspiration Factors
Lead sponsor
Beijing Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
September 30, 2008
Completion date
May 31, 2010
Enrollment
186 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

community-acquired pneumonia